Company intelligence / Profile preview

Llusern Scientific

Cardiff, Wales, United Kingdom

Ownership: Private
Development stage: Other

Overview

Llusern Scientific is a Wales, UK-based biotech company specializing in rapid, lab-accurate, point-of-care molecular diagnostics for bacterial and viral infections, with its initial product focusing on urinary tract infections. The Lodestar DX platform delivers results in 35 minutes and is suitable for use in clinics, pharmacies, and veterinary settings. The UTI panel detects up to six clinically relevant UTI pathogens with accuracy up to 97% when present at clinically relevant levels, supporting targeted antibiotic use and reducing unnecessary prescriptions.

Therapeutic areas: Infectious Diseases
Modalities: Molecular diagnostic testDevice
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Llusern Scientific.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Llusern Scientific.

Explore the full profile